T. Rowe Price Associates’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,365,133
Closed -$923M 3094
2021
Q3
$923M Buy
5,365,133
+65,321
+1% +$11.2M 0.09% 238
2021
Q2
$665M Sell
5,299,812
-58,492
-1% -$7.34M 0.06% 296
2021
Q1
$727M Buy
5,358,304
+48,538
+0.9% +$6.58M 0.07% 276
2020
Q4
$679M Buy
5,309,766
+114,393
+2% +$14.6M 0.07% 275
2020
Q3
$585M Buy
5,195,373
+493,254
+10% +$55.5M 0.07% 280
2020
Q2
$448M Buy
4,702,119
+644,165
+16% +$61.4M 0.06% 311
2020
Q1
$365M Buy
4,057,954
+625,211
+18% +$56.2M 0.06% 306
2019
Q4
$182M Buy
3,432,743
+17,306
+0.5% +$918K 0.02% 497
2019
Q3
$135M Sell
3,415,437
-358,676
-10% -$14.2M 0.02% 533
2019
Q2
$155M Sell
3,774,113
-721,300
-16% -$29.6M 0.02% 522
2019
Q1
$209M Sell
4,495,413
-520,254
-10% -$24.2M 0.03% 455
2018
Q4
$218M Buy
5,015,667
+255,639
+5% +$11.1M 0.04% 414
2018
Q3
$272M Buy
4,760,028
+469,236
+11% +$26.9M 0.04% 404
2018
Q2
$208M Buy
4,290,792
+662,570
+18% +$32.1M 0.03% 473
2018
Q1
$142M Buy
3,628,222
+443,452
+14% +$17.3M 0.02% 553
2017
Q4
$135M Buy
3,184,770
+31,151
+1% +$1.32M 0.02% 548
2017
Q3
$118M Sell
3,153,619
-693,288
-18% -$25.9M 0.02% 580
2017
Q2
$117M Sell
3,846,907
-56,618
-1% -$1.72M 0.02% 552
2017
Q1
$103M Buy
3,903,525
+186,646
+5% +$4.94M 0.02% 595
2016
Q4
$94.9M Buy
3,716,879
+432,113
+13% +$11M 0.02% 614
2016
Q3
$119M Buy
3,284,766
+140,567
+4% +$5.09M 0.02% 535
2016
Q2
$107M Buy
3,144,199
+197,060
+7% +$6.7M 0.02% 547
2016
Q1
$77.8M Buy
2,947,139
+17,660
+0.6% +$466K 0.02% 621
2015
Q4
$143M Sell
2,929,479
-195,522
-6% -$9.53M 0.03% 466
2015
Q3
$77.8M Sell
3,125,001
-22,642
-0.7% -$564K 0.02% 641
2015
Q2
$99.6M Sell
3,147,643
-26,692
-0.8% -$845K 0.02% 602
2015
Q1
$121M Sell
3,174,335
-237,040
-7% -$9.02M 0.03% 559
2014
Q4
$133M Buy
3,411,375
+176,320
+5% +$6.87M 0.03% 531
2014
Q3
$97.8M Sell
3,235,055
-36,672
-1% -$1.11M 0.02% 611
2014
Q2
$111M Buy
3,271,727
+1,427,884
+77% +$48.5M 0.02% 607
2014
Q1
$63.6M Buy
1,843,843
+1,358,043
+280% +$46.9M 0.01% 779
2013
Q4
$19.2M Buy
+485,800
New +$19.2M ﹤0.01% 1107